Biopharmaceuticals
FDA
News Release - October 5, 2006
FDA Approves New Label for VYTORIN(R) (ezetimibe/simvastatin)
Source: Merck/Schering-Plough Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.